GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Artrya Ltd (ASX:AYA) » Definitions » Total Equity

Artrya (ASX:AYA) Total Equity : A$14.69 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Artrya Total Equity?

Artrya's total equity for the quarter that ended in Dec. 2024 was A$14.69 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Artrya Total Equity Historical Data

The historical data trend for Artrya's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artrya Total Equity Chart

Artrya Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Total Equity
51.05 40.64 30.56 16.80

Artrya Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Equity Get a 7-Day Free Trial 35.11 30.56 23.76 16.80 14.69

Artrya Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Artrya's Total Equity for the fiscal year that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=19.012-2.208
=16.80

Artrya's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=16.657-1.968
=14.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Artrya Total Equity Related Terms

Thank you for viewing the detailed overview of Artrya's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Artrya Business Description

Traded in Other Exchanges
N/A
Address
1257 Hay Street, West Perth, Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. It is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. The company is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.

Artrya Headlines

No Headlines